Joseph Eatherly, MD
Pathology · Oak Ridge, TNNPI 1295744753
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Myriad Genetic Laboratories, Inc. accounts for 61.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $504 and has fallen 54.4% since, to $230 in 2025. Among pathology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 74 payments — averaging $21.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$981
- Endo Pharmaceuticals Inc.$78
- 180 Medical, Inc.$59
- Johnson & Johnson$58
- Telix Pharmaceuticals$55
- Sumitomo Pharma America, Inc.$45
- plus $318 from 15 others
What the payments were for
- Food & beverage$1,593100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 36 | $981 |
| Endo Pharmaceuticals Inc. | 6 | $78 |
| 180 Medical, Inc. | 3 | $59 |
| Johnson & Johnson | 4 | $58 |
| Telix Pharmaceuticals | 2 | $55 |
| Sumitomo Pharma America, Inc. | 3 | $45 |
| Urogen Pharma, Inc. | 2 | $38 |
| Bayer | 3 | $38 |
| Amgen | 2 | $34 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $26 |
| Zyla Life Sciences, Inc. | 2 | $22 |
| Smith+Nephew | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Novartis | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Urovant Sciences Inc | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Blue Earth Diagnostics | 1 | $15 |
| Coloplast | 1 | $15 |
| Covidien LP | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$1,593 in reported general payments places this provider in the 95th percentile of 118 pathology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pathology in Oak Ridge
- Yongxin ChenGermantown$820
- Louisa BalazsMemphis$0
- Brandon SmitheyKnoxville$0
- Harrison WarnerNashville$0
- Lan GellertNashville$0
- Aaron ShaverNashville$0
- Christopher ClarkKnoxville$0
- Eugene FongBrentwood$0
- Ehab RabaaMemphis$0
- Emily PattersonJohnson City$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.